MedPath

RENACIDIN

RENACIDIN

Discontinued
DIN Number

00113069

Drug Class

Human

Market Date

Dec 31, 1960

Company
HC

guardian laboratories, division of united-guardian inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00113069
AIG Number0202178001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05CB10 COMBINATIONS
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationTopical ,  Irrigation
AHFS Classification40:36.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CITRIC ACIDActive
Strength: 164 G / 300 G
Monograph: CITRIC ACID
GLUCONIC ACIDActive
Strength: 25 G / 300 G
Monograph: GLUCONIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.